Here I am, once again, CRME is going to be several dollar stock this year.
CEO bought 2M shares late last year, a NEW fund just reported they bought 6.1M shares (and now own 9.9% of the company).
Company is cash rich, no debt, drugs in the pipeline, current sales in Europe.
They just hired a top notch marketing firm.
100% ripe for a buyout or FDA approval sends this quickly.
As for TA, everything is there, crossed the 50/200SMA, the 34/144EMA are setting up for that major cross in just over a week,
blah blah blah blah blah, you probably didn't read this but when it is up 50% next time you will say "what is going on with CRME". LOL
Share This Post:
   
Men in the game are blind to what men looking on see clearly. | |
|
122.84
30.60
